CPT Capital
CPT Capital is a London-based venture capital firm, founded in 2017 and backed by a private family office, that invests exclusively in alternative protein startups — spanning plant-based, fermentation, recombinant, cultivated meat, and enabling technologies — from pre-Seed through IPO. All profits are donated to charity.
- Company typePrivate
- Founded2017
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CPT Capital does
CPT Capital is a London-headquartered venture capital firm founded in 2017 that operates as the investment arm of a private family office and focuses exclusively on the alternative protein sector. The firm invests from the pre-Seed and Seed stages through to sale or IPO, committing to continuous follow-on funding across the lifecycle of its portfolio companies. CPT explicitly donates all profits to charity, aligning its economics with mission-driven impact rather than pure financial return maximization.
The firm's investment universe spans five technology pillars: plant-based proteins (pea, bean, lupin, hemp biomimicry), biomass fermentation (mycoprotein and algae-derived proteins), recombinant proteins (precision fermentation of casein, whey, gelatin), cultivated meat (animal cell growth in bioreactors), and enabling technologies (bioprocess infrastructure, cell line development, and supporting tools). Notable portfolio holdings include category-defining names such as Beyond Meat, Impossible Foods, Upside Foods, Perfect Day, Mosa Meat, Aleph Farms, Bolt Threads, and Shiru, alongside a long tail of earlier-stage bets. Geographically the firm invests across the US, Israel, Europe, the UK, and Asia, sourced through a network of strategic partners and direct founder outreach.
CPT Capital does not develop proprietary technology and its revenue mechanics are typical of a small VC: management fees on committed capital from its family office backer, with carried interest realized only upon portfolio exits. The firm employs roughly six to seven named professionals across investment and corporate functions, including a CFO, Director, Director of Corporate Affairs, Principal, Senior Associate, and Advisor. Pricing is negotiated deal-by-deal; there are no standardized product terms. As a private entity with no public listing, AUM and revenue figures are not disclosed.
CPT Capital firmographics
Firmographics- Name
- CPT Capital
- Legal name
- CPT Capital
- Website
- https://cptcap.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CPT Capital is a London-based venture capital firm, founded in 2017 and backed by a private family office, that invests exclusively in alternative protein startups — spanning plant-based, fermentation, recombinant, cultivated meat, and enabling technologies — from pre-Seed through IPO. All profits are donated to charity.
- Ownership category
- akta.pro rank
CPT Capital industry classification
Industry- Product category
- Venture Capital / Alternative Protein Investment
- NAICS
- Portfolio Management and Investment Advice (523940), Other Financial Vehicles (525990), Other Financial Investment Activities (5239)
- SIC
- Investors, Nec (6799)
- akta.pro primary industry
- Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure) (FSAAALAG)
Keywords
Where CPT Capital is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
CPT Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Investment Returns: As a venture capital firm, CPT Capital generates returns through equity ownership in portfolio companies. They invest capital in exchange for equity stakes and realize returns upon portfolio company exits via sale or IPO. All profits from CPT Capital are donated to charity.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
CPT Capital product offering
Product offeringCore offering
CPT Capital is the venture capital arm of a private family office that invests in alternative protein startups. The firm provides equity capital from pre-Seed and Seed stages through to sale, IPO, or longer term, targeting companies developing plant-based proteins, biomass fermentation, recombinant proteins, cultivated meat, and enabling technologies.
Product overview
CPT Capital is a venture capital firm that serves as the VC arm of a private family office, specializing in alternative protein investments. They invest at pre-Seed and Seed stages with continued backing through to sale, IPO, or longer term. Their investment portfolio spans five categories: Plant-Based Proteins (companies like Beyond Meat, THIS, Redefine Meat, Just, Gathered Foods, Kite Hill, Equinom, Ripple, Yo-Egg, Arda, Alpha Foods, Sunfed Meats, Yo Fix, Omni, FoodHak, Rebellyous Foods), Biomass Fermentation (ENOUGH, Solar Foods, Algama), Recombinant Proteins (Impossible Foods, Perfect Day, Geltor, Formo, New Culture, Remilk, Shiru, Bolt Threads, Change Bio, Asterix Foods, EVERY, Imagindairy, Polopo, Kyomei, Mozza Foods, Motif FoodWorks, Better Dairy, Modern Meadow, TurtleTree Labs), Cultivated Meat (Upside Foods, Aleph Farms, Hoxton Farms, Mosa Meat, Umami Bioworks, Bluu, Wanda Fish, BlueNalu, Prolific Machines, SuperMeat, Vitro Labs, SCiFi Foods, Avant), and Enabling Technologies (MNDL, Liberation Labs, Bright Biotech, BioRaptor, CellRev, Matrix F.T., Veggie Grill).
Differentiator
Problem solved
Functional benefit
Products and services
- Venture Capital Investment Services Provides equity investment capital to visionary founders and alternative protein startups, with commitments from pre-Seed and Seed stages through to sale or IPO, alongside strategic support and access to a network of strategic partners.
Companies that use CPT Capital
Customer profileSegments1 record
Ideal customer profiles1 record
CPT Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
CPT Capital partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor.
- ProVeg IncubatorminorAccelerator program that has supported 116 startups from 38 countries in the alternative protein space. CPT Capital is listed as a potential funding source alongside this accelerator.
- Good Food InstituteminorNon-profit organization providing grants to alternative protein startups. Mentioned as a funding source alongside CPT Capital.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
CPT Capital competitors and assessment
Company assessmentEmerging players
- SOSV: SOSV runs the IndieBio accelerator and HAX, with significant cultivated meat and fermentation investments. It overlaps with CPT Capital in early-stage alt-protein investing but operates an accelerator model rather than direct equity.
Direct peers
- Unovis Asset Management (New Crop Capital): Unovis/New Crop Capital is a dedicated alternative protein venture firm with a long-standing, pure-play focus on the alt-protein sector — directly comparable in thesis and stage to CPT Capital.
- Agronomics: Agronomics is a London-listed investment company focused exclusively on cellular agriculture and alternative proteins — a closely comparable pure-play alt-protein investor with a global portfolio spanning cultivated meat and precision fermentation.
- Prelude Ventures: Prelude Ventures is an early-stage VC focused on climate-tech including food and agriculture, with active alt-protein investments. It is a comparable specialist in climate-aligned food-tech investing.
- Lever VC: Lever VC is a venture firm specifically focused on alternative protein and food tech, investing globally from seed to growth stage. It is comparable to CPT Capital in pure-play thesis, stage focus, and founder-driven deal sourcing.
- Blue Horizon: Blue Horizon is a direct peer — a dedicated impact VC fund focused on alternative proteins and sustainable food, with comparable stage and geographic reach. Both firms are routinely cited as the leading pure-play alt-protein specialist investors globally.
- S2G Ventures: S2G Ventures is a leading food and agriculture VC fund (~$2B AUM) with significant alternative protein exposure across plant-based, fermentation, and cultivated meat. Like CPT Capital, it invests across the alt-protein value chain but at greater scale and with institutional capital.
Broad incumbents
- Obvious Ventures: Obvious Ventures is a mission-driven VC investing across multiple 'world-positive' sectors including alternative proteins. Comparable as an impact-aligned VC with food-tech exposure, though broader than CPT Capital's pure-play mandate.
- Khosla Ventures: Khosla Ventures is a large generalist VC with a high-conviction alt-protein book (e.g., Memphis Meats/Upside Foods, Impossible Foods). Comparable in alternative protein exposure but operates across many other sectors.
- Greenlight Capital: Greenlight Capital is a broader food-tech and sustainability investor with meaningful alternative protein exposure among a wider portfolio; comparable as an adjacent alt-protein investor but not a pure-play specialist.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
CPT Capital social profiles
Digital presenceCPT Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
CPT Capital leadership team
Management profileNumber of profiles
Profiles7 records
CPT Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CPT Capital M&A and investment
M&A and investmentM&A
Investments60 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CPT Capital
What does CPT Capital do?
CPT Capital is the venture capital arm of a private family office that invests in alternative protein startups. The firm provides equity capital from pre-Seed and Seed stages through to sale, IPO, or longer term, targeting companies developing plant-based proteins, biomass fermentation, recombinant proteins, cultivated meat, and enabling technologies.
Is CPT Capital a public or private company?
CPT Capital is a private company. It is classified as family owned and is currently operating.
When was CPT Capital founded?
CPT Capital was founded in 2017. It employs 11 to 50 people.
Where is CPT Capital based?
CPT Capital is headquartered in London, United Kingdom, in the Europe region.
How does CPT Capital make money?
One revenue line is on record: investment Returns.
Who are CPT Capital's main competitors?
SOSV is listed as an emerging player. Direct peers are Unovis Asset Management (New Crop Capital), Agronomics, Prelude Ventures, Lever VC, Blue Horizon and S2G Ventures. Broad incumbents are Obvious Ventures, Khosla Ventures and Greenlight Capital.
Does CPT Capital have an API?
No public API is recorded for CPT Capital.
What industry is CPT Capital in?
CPT Capital's product category is Venture Capital / Alternative Protein Investment. Its primary akta.pro industry code is FSAAALAG, Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure). Its NAICS code is 523940 and its SIC code is 6799.